Understandings of Immunomodulatory Pathways of Indoleamine 2,3-dioxygenase (IDO) in Bladder Cancer Cells

被引：0
|
作者：
Gomes Matheus, Luiz Henrique
Ferreira, Janaina Mendes
Dalmazzo, Stephanie Vanin
Pereira, Lucas Alves
dos Santos, Andressa Assuncao
Alves Rubens dos Santos, Leticia Rafaela
Reis, Sabrina Thalita
Delle, Humberto
机构：
来源：
FASEB JOURNAL | 2019年 / 33卷
基金：
巴西圣保罗研究基金会;
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
704.4
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
    Fujiwara, Yu
    Kato, Shumei
    Nesline, Mary K.
    Conroy, Jeffrey M.
    DePietro, Paul
    Pabla, Sarabjot
    Kurzrock, Razelle
    CANCER TREATMENT REVIEWS, 2022, 110
  • [2] TRANSIENT DOWNREGULATION OF INDOLEAMINE 2,3-DIOXYGENASE (IDO) IS CRITICAL FOR BLADDER CANCER CELL INVASION
    Santos, Hellen Joyce Sousa Pereira
    Dalmazzo, Stephanie Vanin
    Matheus, Luiz Henrique Gomes
    Pereira, Lucas Alves
    Floriani, Marina Baptista
    Delle, Humberto
    FASEB JOURNAL, 2018, 32 (01):
  • [3] Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy
    Guo, Yixuan
    Liu, Yu
    Wu, Wei
    Ling, Daishun
    Zhang, Qiao
    Zhao, Peng
    Hu, Xi
    BIOMATERIALS, 2021, 276
  • [4] Synthesis of indoleamine 2,3-dioxygenase (IDO) inhibitor
    Suzuki, Takafumi
    Yokoyama, Yuuaku
    Tsutumi, Katsuhiko
    Yamaguchi, Tomoyuki
    Takikawa, Osamu
    Okuno, Hiroaki
    JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 2010, 62 (01) : 114 - 115
  • [5] Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
    Selvan, Senthamil R.
    Dowling, John P.
    Kelly, William K.
    Lin, Jianqing
    CURRENT CANCER DRUG TARGETS, 2016, 16 (09) : 755 - 764
  • [6] Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy
    Sarah Yentz
    David Smith
    BioDrugs, 2018, 32 : 311 - 317
  • [7] Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy
    Yentz, Sarah
    Smith, David
    BIODRUGS, 2018, 32 (04) : 311 - 317
  • [8] The indoleamine 2,3-dioxygenase (IDO) pathway controls allergy
    von Bubnoff, D.
    Bieber, T.
    ALLERGY, 2012, 67 (06) : 718 - 725
  • [9] Indoleamine 2,3-dioxygenase (IDO) in inflammation and allergy to Aspergillus
    Romani, Luigina
    Zelante, Teresa
    De Luca, Antonella
    Bozza, Silvia
    Bonifazi, Pierluigi
    Moretti, Silvia
    D'Angelo, Carmen
    Giovannini, Gloria
    Bistoni, Francesco
    Fallarino, Francesca
    Puccetti, Paolo
    MEDICAL MYCOLOGY, 2009, 47 : S154 - S161
  • [10] Indoleamine 2,3-dioxygenase (IDO) expression and malignant transformation in prostate cancer
    Provenzano, M.
    Feder-Mengus, C.
    Wyler, S.
    Hudolin, T.
    Ruszat, R.
    Weber, W. P.
    Sulser, T.
    Bachmann, A.
    Heberer, M.
    Spagnoli, G. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345